Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone

被引：0
|
作者：
Liew, Siew Fai [1 ]
Bhanu, Gupta [1 ]
Lee, Jimmy [1 ]
Chee, Kok Seng [1 ]
Neo, Li Qi [1 ]
Tang, Charmaine [1 ]
机构：
[1] Inst Mental Hlth, Singapore, Singapore
来源：
BJPSYCH OPEN | 2021年 / 7卷
关键词：
D O I：
10.1192/bjo.2021.663
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S247 / S248
页数：4
相关论文
共 50 条
  • [1] Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
    Liew, Siew Fai
    Bhanu, Gupta
    Tang, Charmaine
    Lee, Jimmy
    Chee, Kok Seng
    Neo, Li Qi
    BJPSYCH OPEN, 2021, 7 : S248 - S248
  • [2] Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine
    Machielsen, Marise
    Beduin, Albertine Scheltema
    Dekker, Nienke
    Kahn, Rene S.
    Linszen, Don H.
    van Os, Jim
    Wiersma, Durk
    Bruggeman, Richard
    Cahn, Wiepke
    de Haan, Lieuwe
    Krabbendam, Lydia
    Myin-Germeys, Inez
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (01) : 189 - 195
  • [3] The effects of risperidone and olanzapine on the indications for clozapine
    Ganguli, R
    Brar, JS
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (01) : 83 - 87
  • [4] Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
    Manu, Peter
    Correll, Christoph U.
    Wampers, Martien
    van Winkel, Ruud
    Yu, Weiping
    Shiffeldrim, Daphna
    Kane, John M.
    De Hert, Marc
    SCHIZOPHRENIA RESEARCH, 2013, 143 (2-3) : 358 - 362
  • [5] Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine
    Kelly, DL
    Kreyenbuhl, J
    Love, RC
    Van-Duong, Q
    Conley, RR
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) : 1133 - 1134
  • [6] High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine
    Larsen, Julie R.
    Svensson, Camilla K.
    Vedtofte, Louise
    Jakobsen, Mathilde Lund
    Jespersen, Hans Soe
    Jakobsen, Michelle I.
    Koyuncu, Kamuran
    Schjerning, Ole
    Nielsen, Jimmi
    Ekstrom, Claus T.
    Holst, Jens J.
    Correll, Christoph U.
    Vilsboll, Tina
    Fink-Jensen, Anders
    CNS SPECTRUMS, 2019, 24 (04) : 441 - 452
  • [7] Pharmacoeconomics of clozapine, risperidone and olanzapine - A review of the literature
    Procyshyn, RM
    Thompson, D
    Tse, G
    CNS DRUGS, 2000, 13 (01) : 47 - 76
  • [8] Prolactin response in patients with schizophrenia treated with haloperidol, clozapine, risperidone and olanzapine
    Potkonjak, Jelena
    Karlovic, Dalibor
    Bukovec, Zeljka
    Baricevic, Tihana
    BIOCHEMIA MEDICA, 2009, 19 (01) : 73 - 80
  • [9] Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
    Citrome, L
    Volavka, J
    Czobor, P
    Sheitman, B
    Lindenmayer, JP
    McEvoy, J
    Cooper, TB
    Chakos, M
    Lieberman, JA
    PSYCHIATRIC SERVICES, 2001, 52 (11) : 1510 - 1514
  • [10] Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia
    Mohr, P
    Volavka, J
    Lieberman, JA
    Czobor, P
    McEvoy, J
    Lindenmayer, JP
    Citrome, L
    Sheitman, B
    EUROPEAN PSYCHIATRY, 2000, 15 : 284S - 284S
12345